<DOC>
	<DOCNO>NCT00005602</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs carboplatin lobradimil may make tumor cell sensitive radiation therapy . PURPOSE : Phase I trial study effectiveness combine radiation therapy carboplatin lobradimil treat child newly diagnose brain stem glioma .</brief_summary>
	<brief_title>Radiation Therapy Plus Carboplatin Lobradimil Treating Children With Newly Diagnosed Brain Stem Gliomas</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerated duration lobradimil plus carboplatin radiotherapy patient newly diagnose brain stem glioma . - Determine toxic effect treatment regimen patient . - Assess response radiotherapy patient treat regimen . OUTLINE : Patients receive radiotherapy 5 consecutive day week 6.5 week , total 33 dos . Patients receive carboplatin IV 15 minute follow lobradimil IV 10 minute concurrently radiotherapy . The first cohort 3-6 patient receive treatment carboplatin lobradimil first three week radiotherapy , duration chemotherapy increase one week subsequent cohort maximum duration 6.5 week reach unacceptable toxicity occur 2 6 patient . Patients follow 6 week ; every 3 month 2 year ; every 6 month 3 year ; annually thereafter . PROJECTED ACCRUAL : A total 15-24 patient accrue study within 36 month .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose diffuse , intrinsic brain stem glioma Measurable disease No disseminate disease site brain stem No neurofibromatosis Treatment must begin within 31 day diagnosis Date diagnosis consider date surgery patient undergo surgical biopsy PATIENT CHARACTERISTICS : Age : 3 21 Performance status : Karnofsky 50100 % ( 10 year age ) Lansky 50100 % ( 10 year age ) Life expectancy : At least 2 month Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 10 g/dL Hepatic : Bilirubin le 1.5 time upper limit normal ( ULN ) SGPT great 2.5 time ULN ( 4.0 time ULN antiepileptic steroid medication ) Renal : Creatinine le ULN age OR Creatinine clearance glomerular filtration rate great 80 mL/min Other : No history severe allergic reaction platinumcontaining compound Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy No concurrent growth factor therapy carboplatin Chemotherapy Not specify Endocrine therapy Prior corticosteroid brain stem glioma allow Radiotherapy Not specify Surgery Prior surgery brain stem glioma allow Other At least 24 hour since follow medication : Vasodilating compound Angiotensinconverting enzyme inhibitor Calcium channel blocker Beta blocker No prior therapy brain stem glioma</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>untreated childhood brain stem glioma</keyword>
</DOC>